Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.

ABSTRACT: Recent studies revealed the biological heterogeneity of medulloblastoma, with the existence of at least four groups which are associated with several clinical and morphological features. We investigated for further correlations between molecular types, location of tumours, their contrast enhancement pattern and survival of patients. Altogether 76 tumours were analyzed and molecular subtypes were identified by immunohistochemistry using representative antibodies, detection of chromosome 6 monosomy and CTNNB1 mutation. The site of the tumour was assessed on diagnosis using Magnetic Resonance images and intra-operative surgical reports. In addition, the gadolinium enhancement pattern was also investigated in pre-treatment tumours. Cerebellar hemispheric location was associated with SHH tumour

SUBMITTER: Lastowska M 

PROVIDER: S-EPMC4439433 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature